Yardley, PA – March 01, 2023 – Herspiegel. a leading provider of commercial strategy and implementation services to pharmaceutical and biotech industries, announced today that they have named Matt Righter as their first Executive Vice President of Business Development. Matt’s two decades of experience in the pharmaceutical industry, coupled with his leadership positions across life science service providers, make him an ideal choice to lead business development opportunities for Herspiegel’s comprehensive commercial services.
Brent Herspiegel, CEO, commented, “Matt will serve as an accelerant to our growth as we continue to expand both the depth and scope of our commercial services across a broader array of clients.” Beth Schurman, Herspiegel’s Chief Commercial Officer, added, “Matt’s prior life sciences client-side experience combined with recent business development roles allow him to identify where Herspiegel can solve the complex challenges our clients face.”
Herspiegel, as it celebrates its 15th anniversary, continues to build upon its commercialization services to optimize business outcomes for the world’s largest pharmaceutical companies as well as biotech start-ups executing their first commercialization.
“I am energized to join Herspiegel and work alongside an incredibly talented and experienced team of commercial experts. There is an exciting trajectory of growth built on a solid foundation of achieving commercial success for our clients. I am thrilled to be a part of it,” Matt Righter said about his new role.